Futura Medical PLC (OTCPK:FAMDF)
$ 0.381 -0.034 (-8.19%) Market Cap: 120.65 Mil Enterprise Value: 115.75 Mil PE Ratio: 0 PB Ratio: 10.38 GF Score: 41/100

Futura Medical PLC Highly Positive FM71 Phase 3 Study Results Presentation (Pre-Recorded) Transcript

Aug 31, 2022 / 09:00AM GMT
Release Date Price: $0.59 (+49.37%)
James Henry Barder
Futura Medical plc - CEO & Executive Director

Presentation (Pre-Recorded)
Aug 31, 2022 / 09:00AM GMT

=====================
Corporate Participants
=====================
* James Henry Barder
Futura Medical plc - CEO & Executive Director
* Kenneth William James
Futura Medical plc - Head of R&D & Executive Director

=====================
-

Kenneth William James
Futura Medical plc - Head of R&D & Executive Director

Well, good morning, everybody. My name is James Barder. I'm the CEO of Futura Medical, and I wanted to welcome you to our webcast today, where Ken James, Executive Director and Head of R&D, will go through the excellent results that we have recently achieved on FM71. So without stealing anymore thunder from Ken, let me pass you across to him to go through the results. Ken?

-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot